These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 19674356)

  • 1. Neutropenia in the acute phase of Kawasaki disease and prevention of coronary artery aneurysm.
    Onouchi Z; Hamaoka K; Ozawa S; Sakata K; Kiyosawa N; Ito H
    Pediatr Int; 2009 Aug; 51(4):448-52. PubMed ID: 19674356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventing Long-Term Cardiac Damage in Pediatric Patients With Kawasaki Disease.
    Williams K
    J Pediatr Health Care; 2017; 31(2):196-202. PubMed ID: 27592169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevention of coronary artery aneurysm in Kawasaki disease: a meta-analysis on the efficacy of aspirin and immunoglobulin treatment.
    Durongpisitkul K; Gururaj VJ; Park JM; Martin CF
    Pediatrics; 1995 Dec; 96(6):1057-61. PubMed ID: 7491221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reevaluation of the efficacy of intravenous gammaglobulin in the prevention and treatment of coronary artery lesion in Kawasaki disease.
    Qin L; Saumu MT; Wang H; Shi H; Hu X; Cheng P
    J Huazhong Univ Sci Technolog Med Sci; 2005; 25(3):348-50, 370. PubMed ID: 16201293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of initial corticosteroid therapy on coronary artery aneurysm formation in Kawasaki disease: a meta-analysis of 862 children.
    Wooditch AC; Aronoff SC
    Pediatrics; 2005 Oct; 116(4):989-95. PubMed ID: 16199713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutropenia after intravenous immunoglobulin therapy is associated with coronary artery lesions in children with Kawasaki disease: a case control study.
    Wang Z; Weng F; Li C; Shi H; Tang Z; Qiu H; He Y; Wu R; Chu M
    BMC Pediatr; 2018 Feb; 18(1):76. PubMed ID: 29466965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guideline-Concordant Treatment of Kawasaki Disease With Immunoglobulin and Aspirin and the Incidence of Coronary Artery Aneurysm.
    Michihata N; Matsui H; Fushimi K; Yasunaga H
    Clin Pediatr (Phila); 2015 Oct; 54(11):1076-80. PubMed ID: 25573948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous gamma-globulin for Kawasaki disease.
    Furusho K; Kamiya T; Nakano H; Kiyosawa N; Shinomiya K; Hayashidera T; Tamura T; Hirose O; Manabe Y; Yokoyama T
    Acta Paediatr Jpn; 1991 Dec; 33(6):799-804. PubMed ID: 1801560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kawasaki Disease.
    Newburger JW; Takahashi M; Burns JC
    J Am Coll Cardiol; 2016 Apr; 67(14):1738-49. PubMed ID: 27056781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited.
    Hsieh KS; Weng KP; Lin CC; Huang TC; Lee CL; Huang SM
    Pediatrics; 2004 Dec; 114(6):e689-93. PubMed ID: 15545617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current recommendations for the pharmacologic therapy in Kawasaki syndrome and management of its cardiovascular complications.
    De Rosa G; Pardeo M; Rigante D
    Eur Rev Med Pharmacol Sci; 2007; 11(5):301-8. PubMed ID: 18074939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cardiovascular complications of Kawasaki disease: clinical cases].
    Sica F; d'Amato E; Colapietra T; Romondia A
    Pediatr Med Chir; 1995; 17(6):531-3. PubMed ID: 8668589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of Kawasaki disease in infants younger than six months of age.
    Chang FY; Hwang B; Chen SJ; Lee PC; Meng CC; Lu JH
    Pediatr Infect Dis J; 2006 Mar; 25(3):241-4. PubMed ID: 16511387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incomplete Kawaski disease: are we missing it?
    Billoo AG; Lone SW; Siddiqui S; Atiq H
    J Pak Med Assoc; 2009 Jan; 59(1):42-3. PubMed ID: 19213377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remission of autoimmune neutropenia after development of Kawasaki disease.
    Okada S; Hasegawa S; Suzuki Y; Ichimura T; Kaneyasu H; Shimomura M; Wakabayashi-Takahara M; Nakamura K; Kobayashi M; Ohga S
    Pediatr Int; 2015 Oct; 57(5):1012-4. PubMed ID: 26508185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medium- or Higher-Dose Acetylsalicylic Acid for Acute Kawasaki Disease and Patient Outcomes.
    Kim GB; Yu JJ; Yoon KL; Jeong SI; Song YH; Han JW; Hong YM; Joo CU
    J Pediatr; 2017 May; 184():125-129.e1. PubMed ID: 28043685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of immunoglobulin in the prevention of coronary artery aneurysms in Kawasaki disease].
    Chaker L; Drissa MA; Drissa H
    Tunis Med; 2009 Mar; 87(3):228-9. PubMed ID: 19537024
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute cholestasis: atypical onset of Kawasaki disease.
    Valentini P; Ausili E; Schiavino A; Angelone DF; Focarelli B; De Rosa G; Ranno O
    Dig Liver Dis; 2008 Jul; 40(7):582-4. PubMed ID: 18055284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Kawasaki disease: what you need to know].
    Bajolle F; Laux D
    Arch Pediatr; 2012 Nov; 19(11):1264-8. PubMed ID: 22921712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infections and Kawasaki disease: implications for coronary artery outcome.
    Benseler SM; McCrindle BW; Silverman ED; Tyrrell PN; Wong J; Yeung RS
    Pediatrics; 2005 Dec; 116(6):e760-6. PubMed ID: 16322132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.